+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antifungal prophylaxis in bone marrow transplant recipients Results of a double-blind randomized study of liposomal amphotericin B vs placebo



Antifungal prophylaxis in bone marrow transplant recipients Results of a double-blind randomized study of liposomal amphotericin B vs placebo



Journal of Cellular Biochemistry Suppl. 0(18B): 62




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030118379

Download citation: RISBibTeXText


Related references

Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplantation 12(6): 577-582, 1993

Fluconazole prophylaxis in marrow transplant recipients a randomized placebo controlled double blind study. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 214, 1992

Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies. Transplantation Proceedings 26(3): 1833-1833, 1994

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Annals of Internal Medicine 118(3): 179-184, 1993

Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long term results of a randomized, placebo-controlled trial. Transplantation Proceedings 27(1): 1195-1198, 1995

Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients. American Journal of Hematology 81(4): 299-300, 2006

Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial. American Journal of Transplantation 19(6): 1831-1837, 2019

Prophylactic use of liposomal amphotericin B against fungal infections A randomized trial in bone marrow transplant recipients. Transplantation Proceedings 25(1 BOOK 1-2): 1495-1497, 1993

Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients. Transplantation Proceedings 25(1 Pt 2): 1495-1497, 1993

Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation 59(1): 45-50, 1995

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. Bone Marrow Transplantation 23(2): 163-168, 1999

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood 111(11): 5403-5410, 2008

Ondansetron versus chlorpromazine for preventing emesis in bone marrow transplant recipients: a double-blind randomized study. Journal of ChemoTherapy 5(3): 191-196, 1993

Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transplant International 15(7): 341-347, 2002

Pentoxifylline for prophylaxis of amphotericin B toxicity Results of a randomized double blind placebo controlled clinical trial. Annals of Hematology 73(Suppl. 2): A47, 1996